Earnings History Data for Aytu BioPharma, Inc. (AYTU) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aytu BioPharma, Inc.
Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | AYTU | Aytu BioPharma, Inc. | 10.88 | -0.20 | 0.00 | -1.48 | Aytu BioPharma GAAP EPS of -$0.20 beats by $0.14, revenue of $16.57M beats by $2.8M [11/13/2024 4:44 PM] |
1.55 | -0.20 (-11.17%) |
1.72 | -0.03 (-1.43%) |
1.49 - 3.45 | 151,245 | 50,000 | 4,582 | ||
|
||||||||||||||||||
| 26-09-2024 | AH | AYTU | Aytu BioPharma, Inc. | 14.21 | -0.82 | 0.00 | 0.16 | Aytu BioPharma FY GAAP EPS of -$2.86 misses by $0.37, revenue of $81M misses by $0.33M [9/26/2024 4:28 PM] |
2.35 | -0.50 (-17.51%) |
2.60 | -0.25 (-8.74%) |
1.66 - 3.50 | 226,522 | 20,000 | 9,227 | ||
|
||||||||||||||||||
| 14-02-2024 | AH | AYTU | Aytu BioPharma, Inc. | 16.31 | -0.04 | 0.00 | -1.31 | Aytu BioScience GAAP EPS of -$0.04 beats by $0.21, revenue of $22.93M beats by $1.18M [2/14/2024 4:20 PM] |
3.15 | 0.0 (0.00%) |
3.27 | 0.12 (3.81%) |
1.38 - 3.50 | 22,057 | 30,000 | 5,323 | ||
| 27-09-2023 | AH | AYTU | Aytu BioPharma, Inc. | 6.12 | 0.16 | 0.00 | 5.00 | Aytu BioScience GAAP EPS of -$0.59 beats by $0.36, revenue of $30.73M beats by $3.04M [9/27/2023 4:24 PM] |
2.67 | 0.75 (39.06%) |
1.88 | -0.04 (-2.08%) |
1.38 - 4.88 | 6,228,486 | 30,000 | 5,388 | ||
| 11-05-2023 | AH | After the close (May 11) |
AYTU | Aytu BioPharma, Inc. | 7.75 | -1.93 | 0.00 | -5.40 | Aytu BioScience GAAP EPS of -$1.93 misses by $1.30, revenue of $22.7M misses by $5.3M [5/11/2023 4:11 PM] |
1.84 | -0.28 (-12.97%) |
2.14 | 0.02 (0.94%) |
1.40 - 16.19 | 100,867 | 140,000 | 824 | |
| 21-02-2023 | AH | After the close (Feb 14) |
AYTU | Aytu BioPharma | 9.00 | -1.31 | 0.20 | 0.00 | Aytu BioScience GAAP EPS of -$2.15, revenue of $26.28M [2/21/2023 4:23 PM] |
2.74 | -0.20 (-6.80%) |
3.07 | 0.13 (4.42%) |
2.74 - 26.80 | 110,585 | 40,000 | 140 | |
| 14-11-2022 | AH | AYTU | Aytu BioPharma, Inc. | 9.96 | -0.06 | 0.00 | -0.33 | Aytu BioScience GAAP EPS of -$0.06, revenue of $27.66M [11/14/2022 4:09 PM] |
0.1955 | -0.01 (-3.22%) |
0.21 | 0.0 (1.93%) |
0.15 - 2.54 | 1,847,788 | 850,000 | 216,240 | ||
| 27-09-2022 | AH | 7:20 PM ET (Sep 27) |
AYTU | Aytu BioPharma, Inc. | 12.00 | -0.25 | -0.24 | -0.67 | Aytu BioScience GAAP EPS of -$0.49 misses by $0.12, revenue of $27.45M beats by $1.95M [9/27/2022 4:12 PM] |
0.1960 | 0.01 (3.16%) |
0.19 | 0.0 (-2.58%) |
0.18 - 3.06 | 2,234,245 | 1,070,000 | 366,183 | |
|
||||||||||||||||||
| 15-11-2021 | AH | 4:05 PM ET (Nov 15) |
AYTU | Aytu BioPharma, Inc. | 66.68 | -0.33 | 0.00 | -0.40 | Aytu BioScience EPS misses by $0.60, misses on revenue [11/15/2021 4:18 PM] |
2.20 | -0.25 (-10.20%) |
2.34 | -0.11 (-4.49%) |
2.19 - 11.76 | 626,757 | 370,000 | 2,219 | |
| 17-05-2021 | AH | 4:05 PM ET (May 17) |
AYTU | Aytu BioPharma, Inc. | 122.53 | -0.17 | -0.36 | -1.50 | Aytu BioScience EPS misses by $1.08, misses on revenue [5/17/2021 4:19 PM] |
5.42 | -0.19 (-3.39%) |
5.31 | -0.30 (-5.33%) |
5.09 - 17.00 | 513,415 | 540,000 | 12,210 | |
| 11-02-2021 | AH | AYTU | Aytu BioScience, Inc. | 148.61 | -0.47 | -0.50 | -3.10 | Aytu BioScience EPS misses by $0.28, beats on revenue [2/11/2021 4:55 PM] |
8.56 | -0.18 (-2.06%) |
8.32 | -0.42 (-4.81%) |
3.35 - 29.90 | 504,210 | 660,568 | 24,298 | ||
| 12-11-2020 | AH | AYTU | Aytu BioScience, Inc. | 127.10 | -0.40 | -0.06 | -0.32 | Aytu BioScience EPS beats by $0.02, beats on revenue [11/12/2020 4:35 PM] |
0.9696 | -0.06 (-5.86%) |
0.99 | -0.04 (-3.88%) |
0.34 - 2.99 | 3,934,046 | 2,307,565 | 203,300 | ||
|
|
||||||||||||||||||
| 14-05-2020 | AH | AYTU | Aytu BioScience, Inc. | 156.10 | -1.50 | -0.39 | -0.50 | Aytu BioScience EPS misses by $0.10, beats on revenue [5/14/2020 4:13 PM] |
1.56 | -0.22 (-12.36%) |
1.54 | -0.02 (-1.28%) |
0.34 - 2.99 | 17,358,070 | 10,579,952 | 455,386 | ||
|
|
||||||||||||||||||